5 Vials of 20mg Cartalax

Cartalax 20mg – Cellular Regeneration Peptide for Tissue Repair & Recovery

Cartalax is a peptide bioregulator complex isolated from cartilage tissue, investigated for its role in extracellular matrix synthesis and chondrocyte gene expression. It influences peptide signaling pathways that regulate collagen metabolism and tissue elasticity. Cartalax is used in studies exploring connective tissue peptide regulation and articular cell maintenance.

For research use only. Not for human consumption.

Cartalax (also known as AED or AC-4) is a tripeptide complex (alanine-glutamic acid-aspartic acid) that modulates cartilage and bone metabolism by targeting cellular pathways in chondrocytes and thyroid C cells.

Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.